|
Model Number SPM-35 |
Device Problems
Degraded (1153); Adverse Event Without Identified Device or Use Problem (2993); Material Split, Cut or Torn (4008)
|
Patient Problems
Abscess (1690); Adhesion(s) (1695); Purulent Discharge (1812); Unspecified Infection (1930); Ischemia (1942); Necrosis (1971); Staphylococcus Aureus (2058); Scarring (2061); Seroma (2069); Discharge (2225); Hernia (2240); Injury (2348); Obstruction/Occlusion (2422); Ascites (2596); Abdominal Distention (2601); Fibrosis (3167); No Code Available (3191)
|
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of an umbilical hernia.
It was reported that after implant, the patient experienced wound seroma, palpable masses above and below umbilicus filled with fluid, incarcerated recurrent hernia, small bowel obstruction, incarcerated segment of small bowel within hernia, involvement of the entire abdominal wall creating swiss cheese effect, defect measuring 20cmx20cm, recurrent incarcerated ventral hernia, a volvulizedsegment of jejunum was noted to be incarcerated, adhesions, infected mesh, small bowel mass, posterior mesh adherent to bowel, and multiple abscesses found in conjunction with the mesh.
Post-operative treatment included incarcerated recurrent umbilical hernia repair with mesh, incarcerated recurrent ventral hernia repair with mesh, small bowel resection, anastomosis, lysis of adhesions, wound debridement of previous incision site, mesh revision surgery, removal of infected mesh, debridement of subcutaneous tissues and underlying skin,.
|
|
Manufacturer Narrative
|
This information was received as a part of an extensive mesh litigation submission to medtronic.
The fda was notified of this large complaint receipt.
Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of an umbilical hernia.
It was reported that after implant, the patient experienced wound seroma, palpable masses above and below umbilicus filled with fluid, incarcerated recurrent hernia, small bowel obstruction, incarcerated segment of small bowel within hernia, involvement of the entire abdominal wall creating swiss cheese effect, defect measuring 20cmx20cm, recurrent incarcerated ventral hernia, a volvulizedsegment of jejunum was noted to be incarcerated, adhesions, infected mesh, small bowel mass, posterior mesh adherent to bowel, scar, and multiple abscesses found in conjunction with the mesh.
Post-operative treatment included incarcerated recurrent umbilical hernia repair with mesh, incarcerated recurrent ventral hernia repair with mesh, small bowel resection, anastomosis, lysis of adhesions, wound debridement of previous incision site, mesh revision surgery, removal of infected mesh, debridement of subcutaneous tissues and underlying skin, creation of bilateral skin advancement flap, scar revision.
|
|
Search Alerts/Recalls
|
|
|